University of Rhode Island Clinical Professor of Pharmacy Jeffrey Bratberg partnered with Brandeis University and Boston ...

JailsoutpaceprisonsinofferingMOUD,butregionaldisparitiesandlimitedtreatmentaccess persist across the U.S. Qualitativefeedbackpointstoneedforgreaterreentrysupport,housing,carecoord ...

Patients who are prescribed higher daily doses of the medication buprenorphine for opioid use disorder are significantly more ...

Early evidence suggests GLP-1s were linked to lower risks of developing substance use disorders — from alcohol to opioids — and to fewer overdoses and deaths in people with existing addictions.

Opioid use disorder (OUD) is a serious and complex condition affecting millions of people across the country and contributing to a national public health emergency. Yet stigma and misinformation about ...

Individuals with opioid use disorder can get “stuck” in particular patterns of brain activity, a new Yale study finds. And this stickiness is more pronounced after they’ve seen images related to ...

Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, ...

The national Six Remnant Defendants lawsuit was brought Feb. 23. The total compensation paid to participating governments ...

Dr. Sarah Spencer sits in the back of the Ninilchik Community Clinic's mobile clinic, assembling an opioid harm-reduction kit. Medications like buprenorphine are important tools in the spectrum of ...

Hospitals in Marion County have been selected to take part in a new, six-month pilot program run by the Oregon Health Authority to improve addiction care in emergency settings. OHA partnered with the ...

Cannabis compounds may reduce symptoms for some disorders, but evidence quality is low ...